Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors

Fig. 2

Estimated TGR0 and TGRTx–Tx. *Pre-treatment TGR (TGR0) is calculated from the second imaging test during the screening period (performed 12–24 weeks after the first screening period scan). LS means and P-values are derived from a mixed model with repeated measures. CI, confidence interval; LS, least squares; TGR, tumor growth rate; TGR0, pre-treatment TGR, TGRTx–Tx, TGR between consecutive study visits during treatment

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us